Dysregulated signalling pathways driving anticancer drug resistance

N Bou Antoun, AM Chioni - International journal of molecular sciences, 2023 - mdpi.com
One of the leading causes of death worldwide, in both men and women, is cancer. Despite
the significant development in therapeutic strategies, the inevitable emergence of drug …

Recent update and drug target in molecular and pharmacological insights into autophagy modulation in cancer treatment and future progress

MA Rahman, ASM Saikat, MS Rahman, M Islam… - Cells, 2023 - mdpi.com
Recent evidence suggests that autophagy is a governed catabolic framework enabling the
recycling of nutrients from injured organelles and other cellular constituents via a lysosomal …

ROS responsive nanoparticles encapsulated with natural medicine remodel autophagy homeostasis in breast cancer

X Zhang, H Gao, D Wei, X Pei, Y Zhang… - … Applied Materials & …, 2023 - ACS Publications
In photodynamic therapy (PDT), elevated reactive oxygen species (ROS) activate tumor cell
protective autophagy, therefore attenuating the antitumor function of therapy. Hence …

Breast cancer chemoresistance: Insights into the regulatory role of lncRNA

ST Ahmadpour, C Orre, PS Bertevello… - International journal of …, 2023 - mdpi.com
Long noncoding RNAs (lncRNAs) are a subclass of noncoding RNAs composed of more
than 200 nucleotides without the ability to encode functional proteins. Given their …

Ipatasertib exhibits anti‑tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer in vitro and in vivo

J O'donnell, Z Zhao, L Buckingham… - International …, 2023 - spandidos-publications.com
Endometrial cancer is the most common gynecologic cancer and one of the only cancers for
which incidence and mortality is steadily increasing. Although curable with surgery in the …

Flubendazole enhances the inhibitory effect of paclitaxel via HIF1α/PI3K/AKT signaling pathways in breast cancer

Y Zhou, M Liao, Z Li, J Ye, L Wu, Y Mou, L Fu… - International Journal of …, 2023 - mdpi.com
Paclitaxel, a natural anticancer drug, is widely recognized and extensively utilized in the
treatment of breast cancer (BC). However, it may lead to certain side effects or drug …

Emerging roles of interactions between ncRNAs and other epigenetic modifications in breast cancer

J Xie, L Gan, B Xue, X Wang, X Pei - Frontiers in Oncology, 2023 - frontiersin.org
Up till the present moment, breast cancer is still the leading cause of cancer-related death in
women worldwide. Although the treatment methods and protocols for breast cancer are …

Focusing on the role of natural products in overcoming cancer drug resistance: An autophagy-based perspective

J Yao, C Ma, K Feng, G Tan, Q Wen - Biomolecules, 2022 - mdpi.com
Autophagy is a critical cellular adaptive response in tumor formation. Nutritional deficiency
and hypoxia exacerbate autophagic flux in established malignancies, promoting tumor cell …

Desloratadine alleviates ALS-like pathology in hSOD1G93A mice via targeting 5HTR2A on activated spinal astrocytes

J Lu, A He, Z Jin, M Zhang, Z Li, F Zhou, L Ma… - Acta Pharmacologica …, 2024 - nature.com
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with progressive
loss of motor neurons in the spinal cord, cerebral cortex and brain stem. ALS is …

[HTML][HTML] mTOR inhibitor introduce disitamab vedotin (RC48-ADC) rechallenge microtubule-chemotherapy resistance in HER2-low MBC patients with PI3K mutation

Y Hu, F Chen, S Sun, L Xv, X Wang, M Wang… - Frontiers in …, 2024 - frontiersin.org
This study aimed to explore the efficacy and potential mechanisms of rechallenge therapy
with microtubule-targeting agents (MTAs) in patients with HER2-low metastatic breast …